AstraZeneca pays $600m for Chinese lung cancer drug rights

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 4 hours ago

Apple’s Tim Cook sees Australia’s social media curbs as ’world-leading’, PM says

Investing.com

stocksabout 6 hours ago

Venezuela leader Rodriguez signs agreement with French Oil Company Total Energies

Investing.com

stocksabout 8 hours ago

AI safety efforts will require more compute, not less: experts

Investing.com